LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
Article in Cancer Gene Therapy (January 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Cancer Gene Therapy (January 2024)
Article in PeerJ (August 2022)
Article in Renal Failure (August 2022)